AR042237A1 - Obtencion de estructuras cocleares, composiciones vacunales, adyuvantes y sus intermediarios - Google Patents

Obtencion de estructuras cocleares, composiciones vacunales, adyuvantes y sus intermediarios

Info

Publication number
AR042237A1
AR042237A1 ARP030104387A ARP030104387A AR042237A1 AR 042237 A1 AR042237 A1 AR 042237A1 AR P030104387 A ARP030104387 A AR P030104387A AR P030104387 A ARP030104387 A AR P030104387A AR 042237 A1 AR042237 A1 AR 042237A1
Authority
AR
Argentina
Prior art keywords
obtaining
structures
coclear
intermediaries
assistants
Prior art date
Application number
ARP030104387A
Other languages
English (en)
Inventor
Martin Oliver German Perez
Grandos Gustavo Rafael Brancho
Gonzalez Miriam De San Juan Bosco Lastre
Vignier Caridad Zayas
Gonzalez Victoriano Gustavo Sierra
Huergo Concepcion Campa
Gonzalez Nestor Mora
Morales Ramon Faustino Barbera
Campo Alonso Judith Monica Del
Ramirez Tamara Rodriguez
Martinez Danay Gil
Suarez Carlos Taboada
Original Assignee
Inst Finlay Ct De Investigacio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Finlay Ct De Investigacio filed Critical Inst Finlay Ct De Investigacio
Publication of AR042237A1 publication Critical patent/AR042237A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/008—Leishmania antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Botany (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Otolaryngology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

Métodos de obtención de estructuras cocleares a partir de vesículas de membrana externa (ampollas) de microorganismos, con el fin de emplearlas como adyuvantes o como vacunas en si. Las vesículas de membrana externa se obtienen a partir de bacterias, protozoarios o células animales, opcionalmente la composición vacunal incluye proteínas naturales o recombinantes, péptidos, sacáridos, ácidos nucleicos, conjugados o alergenos.
ARP030104387A 2002-11-27 2003-11-27 Obtencion de estructuras cocleares, composiciones vacunales, adyuvantes y sus intermediarios AR042237A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU20020292A CU23313A1 (es) 2002-11-27 2002-11-27 Mã0/00todo de obtenciã"n de estructuras cocleares. composiciones vacunales y adyuvantes basados en estructuras cocleares y sus intermediarios

Publications (1)

Publication Number Publication Date
AR042237A1 true AR042237A1 (es) 2005-06-15

Family

ID=40122451

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030104387A AR042237A1 (es) 2002-11-27 2003-11-27 Obtencion de estructuras cocleares, composiciones vacunales, adyuvantes y sus intermediarios

Country Status (14)

Country Link
US (1) US20060134134A1 (es)
EP (2) EP2347764A3 (es)
CN (1) CN1744883B (es)
AR (1) AR042237A1 (es)
AT (1) ATE530166T1 (es)
AU (1) AU2003281911A1 (es)
BR (1) BR0316687A (es)
CA (1) CA2518906A1 (es)
CU (1) CU23313A1 (es)
DK (1) DK1602360T3 (es)
ES (1) ES2376227T3 (es)
HK (1) HK1088827A1 (es)
WO (1) WO2004047805A1 (es)
ZA (1) ZA200504729B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8642046B2 (en) * 2007-10-09 2014-02-04 Tufts University Cholera vaccines
CU20080215A7 (es) 2008-11-19 2012-06-21 Inst Finlay Vacunas unitemporales
WO2011027956A2 (ko) 2009-09-04 2011-03-10 주식회사이언메딕스 그람 양성 박테리아에서 유래한 세포밖 소포체 및 이를 이용한 질병 모델
CU20100083A7 (es) 2010-05-05 2012-06-21 Inst Finlay Tolerogenos adyuvados como vacuna de malaria
CU20110202A7 (es) * 2011-11-02 2013-12-27 Inst Finlay Ct De Investigación Producción De Sueros Y Vacunas Composición inmunogénica de polisacáridos planos adyuvados y las formulaciones resultantes
EP2689775A1 (en) 2012-07-25 2014-01-29 Instituto Finlay, Centro de Investigacion-Produccion de vacunas y sueros Cochleate with only one mamp
WO2021031270A1 (zh) * 2019-08-22 2021-02-25 四川大学 细菌膜囊泡及其分离制备系统和方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US597572A (en) * 1898-01-18 Indicator for oil-wells
CH588887A5 (es) 1974-07-19 1977-06-15 Battelle Memorial Institute
GB1578776A (en) 1976-06-10 1980-11-12 Univ Illinois Hemoglobin liposome and method of making the same
GB2026340B (en) 1978-07-03 1982-12-22 Ash P Stabilising microvesicles
DE2848965A1 (de) 1978-11-11 1980-05-22 Behringwerke Ag Verfahren zur herstellung von membranproteinen aus neisseria meningitidis und diese enthaltende vaccine
US4271147A (en) 1980-01-10 1981-06-02 Behringwerke Aktiengesellschaft Process for the isolation of membrane proteins from Neisseria meningitidis and vaccines containing same
US4663161A (en) 1985-04-22 1987-05-05 Mannino Raphael J Liposome methods and compositions
RU2023448C1 (ru) 1987-07-30 1994-11-30 Сентро Насьональ Де Биопрепарадос Способ получения вакцины против различных патогенных серотипов менингита нейссера группы в
WO1993014744A1 (en) * 1992-02-04 1993-08-05 Chiron Corporation Non-toxic lipid vaccine formulations
US5643574A (en) * 1993-10-04 1997-07-01 Albany Medical College Protein- or peptide-cochleate vaccines and methods of immunizing using the same
US5994318A (en) * 1993-10-04 1999-11-30 Albany Medical College Cochleate delivery vehicles
US5851536A (en) 1995-11-22 1998-12-22 University Of Washington Therapeutic delivery using compounds self-assembled into high axial ratio microstructures
US5834015A (en) * 1996-09-11 1998-11-10 Albany Medical College Protein-lipid vesicles and autogenous vaccine comprising the same
US6180114B1 (en) 1996-11-21 2001-01-30 University Of Washington Therapeutic delivery using compounds self-assembled into high axial ratio microstructures
GB9918319D0 (en) 1999-08-03 1999-10-06 Smithkline Beecham Biolog Vaccine composition
NO20002828D0 (no) * 2000-06-02 2000-06-02 Statens Inst For Folkehelse Proteinholdig vaksine mot Neisseria meningtidis serogruppe samt fremgangsmÕte ved fremstilling derav
GB0103170D0 (en) * 2001-02-08 2001-03-28 Smithkline Beecham Biolog Vaccine composition

Also Published As

Publication number Publication date
HK1088827A1 (en) 2006-11-17
EP1602360A1 (en) 2005-12-07
CA2518906A1 (en) 2004-06-10
CN1744883A (zh) 2006-03-08
CN1744883B (zh) 2011-06-08
ATE530166T1 (de) 2011-11-15
BR0316687A (pt) 2005-10-18
EP1602360B1 (en) 2011-10-26
EP2347764A2 (en) 2011-07-27
ES2376227T3 (es) 2012-03-12
ZA200504729B (en) 2006-09-27
CU23313A1 (es) 2008-09-25
EP2347764A3 (en) 2011-10-26
DK1602360T3 (da) 2012-02-13
AU2003281911A1 (en) 2004-06-18
US20060134134A1 (en) 2006-06-22
WO2004047805A1 (es) 2004-06-10

Similar Documents

Publication Publication Date Title
CY1112105T1 (el) Ανοσογονα βακτηριακα κυστιδια με πρωτεϊνες εξωτερικης μεμβρανης
ES2139553T1 (es) Replicacion de virus de la gripe en un cultivo de celulas de mamiferos y produccion de vacuna.
NO20054608L (no) Influensavirusvaksine
EA200900784A1 (ru) Вакцины, включающие антиген из четырех штаммов вируса гриппа
CY1111378T1 (el) Προερχομενα απο κυτταρα ιικα εμβολια με χαμηλα επιπεδα υπολειμματικου κυτταρικου dna
AR059772A1 (es) Composiciones que incuyen hemaglutinina metodos de elaboracion y metodos de uso de las mismas
ATE412761T1 (de) Methode um rekombinante proteine in cho zellen zu exprimieren
NO20023829D0 (no) Proteosom influensavaksine
AR068507A1 (es) Construcciones vector fluorocarbonado-antigeno para el suministro de antigenos ifluenza
PT1487485E (pt) Adjuvantes de imidazoquinolina para vacinas de adn
HRP20220924T1 (hr) Imunoterapija zasnovana na pd-l1
DE602004025996D1 (de) Immortalisierte Entezelllinien zur Viruserzeugung
EA200801756A1 (ru) Противогриппозные вакцины, содержащие гемагглютинин и белки матрикса
BRPI0411519A (pt) membrana viral reconstituìda, método para produzir uma membrana viral reconstituìda, e, composição farmacêutica
PL1951300T3 (pl) Zmiana równowagi TH1/TH2 w szczepionkach typu split przeciwko grypie zawierających adjuwant
ECSP066916A (es) Vacuna contra estreptococo agalactiae
UY27059A1 (es) Preparaciones para potenciar la inmunogenecidad de antígenos poco inmunogénicos
AR042237A1 (es) Obtencion de estructuras cocleares, composiciones vacunales, adyuvantes y sus intermediarios
DK1526840T3 (da) Nanopartikler til DNA administration til et målorgan
DE602004028029D1 (en) Rwendung
Stuart et al. Cassette-based presentation of SIV epitopes with recombinant gas vesicles from halophilic archaea
ES2561483T3 (es) Antígenos mutantes de GAS57 y anticuerpos de GAS57
AR041086A1 (es) Vacuna
CY1107560T1 (el) Ζωντανα εξασθενημενα βακτηρια για χρηση σε εμβολιο
CO5650177A2 (es) Constructos geneticos y composiciones que comprenden rre y cte y usos de estos

Legal Events

Date Code Title Description
FB Suspension of granting procedure